Pronađeno: 1-2 / 2 radova

Autori: Samarzija Miroslav

>> Filter: Samo Article i Review

>> Sve godine

Naslov Effect of trilaciclib, a CDK 4/6 inhibitor, on myelosuppression in patients with previously treated extensive-stage small cell lung cancer receiving topotecan. (Meeting Abstract)
Autori Hart Lowell L Andric Zoran G  ... Radosavljevic Davorin Z Jovanovic Dragana ... Samarzija Miroslav Zaric Bojan  ... (broj koautora 20) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2019), vol. 37 br. 15, Suppl. S, str. -
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma. (Meeting Abstract)
Autori Ramalingam Suresh S Zaric Bojan  Ceric Timur ... Samarzija Miroslav ... Vukovic Vojislav M (broj koautora 20) 
Info JOURNAL OF CLINICAL ONCOLOGY, (2014), vol. 32 br. 15, Suppl. S, str. -
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX